Skip to main content
Equibles

Zach Scheiner

Board Member

LENZ Therapeutics, Inc. (LENZ)

Equibles does not estimate personal net worth.

Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get LENZ alerts

About Zach Scheiner

Zach Scheiner is recorded as Board Member at LENZ Therapeutics, Inc. (LENZ) since March 21, 2024. LENZ Therapeutics, Inc. reported in an 8-K filed July 2, 2026 that Zach Scheiner resigned as member of the Company's Board of Directors, effective June 30, 2026. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Zach Scheiner was appointed Class III director, effective March 21, 2024. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Daniel Chevallard (CEO and CFO), Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member) and 6 others.

“On June 30, 2026, Zach Scheiner notified LENZ Therapeutics, Inc. a Delaware corporation (the "Company") of his resignation as a member of the Company's Board of Directors (the "Board") and from all committees of the Board on which he served, effective immediately.”
LENZ Therapeutics, Inc. Form 8-K, filed July 2, 2026 · Read the filing
“Effective as of the Effective Time, Frederic Guerard and James McCollum were appointed as Class I directors, Jeff George, Shelley Thunen, and Evert Schimmelpennink were appointed as Class II directors and Kimberlee C. Drapkin and Zach Scheiner were appointed as Class III directors.”
LENZ Therapeutics, Inc. Form 8-K, filed March 22, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at LENZ Therapeutics, Inc.

Recent activity